Catalyst Wire Dossier Catalyst Wire Dossier

sartan medicines

· Zhejiang Huahai (under supervision)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for sartan medicines, covering 2018-10-15 to 2018-10-15. Get the full timeline:

Most recent: EU authorities take further action in ongoing review of sartans: Zheijiang Huahai placed under increased supervision; Aurobindo Pharma stopped from supplying irbesartan to the EU

See pricing